Skip to main content
. 2020 May 10;40(7):1701–1712. doi: 10.1111/liv.14491

FIGURE 3.

FIGURE 3

Distributional plots of serum MFAP4 in the training and validation cohorts. Distributional plots of serum MFAP4 according to advanced fibrosis and cirrhosis in the training and validation cohorts. Rule‐in and rule‐out cut‐offs are marked with a red line. A&B: MFAP4 > 89.3 (U/L) can be used to rule in advanced fibrosis and a MFAP4 < 46.3 (U/L) can be used to rule out advanced fibrosis in the training (A) and the validation cohort (B). C&D: MFAP4 > 104.8 (U/L) can be used to rule in cirrhosis and a MFAP4 < 79.3 (U/L) can be used to rule out cirrhosis in the training (C) and the validation cohort (D)